It is plausible that the propagated downstream effects of the combinatorial inhibition of MEK1/2 and BMP2 result in targeting of the same substrates involved in cell survival, invasion and migration of MPNST cells. This evidence concerns the gene MAP2K1 and malignant peripheral nerve sheath tumor.